Private Advisor Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-61,816
| Closed | -$119K | – | 2403 |
|
|
2025
Q1 | $119K | Hold |
61,816
| – | – | ﹤0.01% | 2177 |
|
|
2024
Q4 | $117K | Buy |
61,816
+3,000
| +5% | +$5.7K | ﹤0.01% | 2159 |
|
|
2024
Q3 | $77.6K | Sell |
58,816
-810
| -1% | -$1.07K | ﹤0.01% | 2328 |
|
|
2024
Q2 | $60.8K | Buy |
+59,626
| New | +$60.8K | ﹤0.01% | 2261 |
|
|
2024
Q1 | – | Sell |
-20,235
| Closed | -$25.1K | – | 2286 |
|
|
2023
Q4 | $25.1K | Buy |
20,235
+4,094
| +25% | +$5.08K | ﹤0.01% | 2183 |
|
|
2023
Q3 | $18.4K | Buy |
+16,141
| New | +$18.4K | ﹤0.01% | 2015 |
|
|
2022
Q3 | – | Sell |
-20,316
| Closed | -$7K | – | 1912 |
|
|
2022
Q2 | $7K | Buy |
+20,316
| New | +$7K | ﹤0.01% | 2096 |
|
|
2020
Q3 | – | Sell |
-1,860
| Closed | -$25K | – | 1611 |
|
|
2020
Q2 | $25K | Buy |
+1,860
| New | +$25K | ﹤0.01% | 2453 |
|